Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Blocking certain immune signals can reduce skin damage from radiation therapy.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Oral minipulse therapy effectively treated bullous lichen planus in a 35-year-old woman.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.